epa09719338 A Thai medical worker displays a multi-dose vial of Pfizer COVID-19 vaccine for children as they prepare to administer children aged between five and 11 with vaccine at the Queen Sirikit National Institute of Child Health in Bangkok, Thailand, 31 January 2022. Thailand on 31 January started its vaccination drive against COVID-19 for children aged between five and 11-year-old. Children with underlying health conditions will be prioritized. According to the National News Bureau of Thailand, the primary vaccination schedule for children in the 5-11 age bracket requires two doses, each administered three to 12 weeks apart. The Pfizer-BioNTech vaccine is currently the only COVID-19 vaccine approved for young children by Thailand's Food and Drug Administration. EPA/NARONG SANGNAK/Narong Sangnak

Rezultati ohrabruju

Farmaceutski gigant prestaje s proizvodnjom cjepiva za Covid-19: Prebacuju fokus na drugi lijek

Akvizicija će BioNTechu na globalnoj razini osigurati prava na potencijalni budući lijek BNT327, koji je već u poodmakloj fazi kliničkog razvoja, uz "ohrabrujuće rezultate" kliničkih ispitivanja, istaknuli su u njemačkoj kompaniji